Rankings
▼
Calendar
HROW Q2 2019 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena
HROW
Harrow Health, Inc.
$1B
Q2 2019 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$14M
+30.2% YoY
Gross Profit
$8M
61.3% margin
Operating Income
-$767,000
-5.7% margin
Net Income
-$2M
-17.6% margin
EPS (Diluted)
$-0.09
QoQ Revenue Growth
+10.0%
Cash Flow
Operating Cash Flow
$844,000
Free Cash Flow
$387,000
Stock-Based Comp.
$367,000
Balance Sheet
Total Assets
$65M
Total Liabilities
$30M
Stockholders' Equity
$35M
Cash & Equivalents
$4M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$14M
$10M
+30.2%
Gross Profit
$8M
$6M
+33.1%
Operating Income
-$767,000
-$624,000
-22.9%
Net Income
-$2M
$3M
-194.3%
Revenue Segments
License Revenues
$7,000
100%
← FY 2019
All Quarters
Q3 2019 →